Hudson Bay Capital Management
INBS icon

Hudson Bay Capital Management’s Intelligent Bio Solutions INBS Stock Holding History

Hudson Bay Capital Management’s Portfolio INBS Stock Details INBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,825
Closed -$457K – 853
2024
Q1 		$457K Buy
+10,825
New +$448K ﹤0.01% 585

Other funds holding INBS

ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hudson Bay Capital Management's INBS Position: Q2 2024 in Review

Hudson Bay Capital Management sold out of Intelligent Bio Solutions (INBS) in Q2 2024, closing a stake of 10,825 shares — an estimated $457K sold.

Hudson Bay Capital Management first reported a position in INBS in Q1 2024 and held it in 1 quarter. The position peaked at $457K in Q1 2024. 8 funds tracked by Wall St. Rank hold INBS as of Q2 2024.

  • Hudson Bay Capital Management reported no remaining Intelligent Bio Solutions position as of Q2 2024 after selling out during the quarter.
  • Hudson Bay Capital Management sold 10,825 Intelligent Bio Solutions shares in Q2 2024, an estimated $457K.
  • Hudson Bay Capital Management first reported a position in Intelligent Bio Solutions in Q1 2024 and held it in 1 quarter.
  • Hudson Bay Capital Management's Intelligent Bio Solutions position peaked at $457K in Q1 2024.
  • 8 funds tracked by Wall St. Rank held Intelligent Bio Solutions as of Q2 2024.

Based on Hudson Bay Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.